Risk assessment in pulmonary arterial hypertension
Why the study?
What are the merits and limitations of different risk assessment methods in pulmonary arterial hypertension?
Structured PICO
What are the merits and limitations of different risk assessment methods in pulmonary arterial hypertension?
P
Population
Patients with pulmonary arterial hypertension (PAH)
I
Intervention
Risk assessment methods (including 2015 ESC/ERS PH guidelines risk variables, French registry risk equation, and REVEAL registry risk score)
Comprehensive patient assessment and risk stratification using established guidelines and scores are essential for guiding treatment and monitoring disease progression in PAH.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Risk stratification informs PAH monitoring now; leaves open prospective validation for refined individual predictions.
Cite This Study
Raina et al. (2016) studied this question.